Secondary endpoint and responder analyses in a study of rosiglitazone XR in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease

✍ Scribed by Alderton, Claire; Zvartau-Hind, Marina; Ritchie, Sally; Saunders, Ann; Craft, Suzanne; Landreth, Gary; Linnamägi, Ülla; Sawchak, Sharon; Gold, Michael

• Book ID: 122626050
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 47 KB
• Volume: 5
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2009.04.271